Tradestie Institutional Equity Comparison Engine

OKYO vs INDP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

INDP Overall Edge

INDP Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Indaptus Therapeutics, Inc. Common Stock (INDP) driven by superior Momentum & Technical while OKYO counters with relative strength in Growth & Margin. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus INDP at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INDP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
OKYO N/M vs INDP N/M Fwd P/E
Growth & Margin Winner OKYO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner INDP
1Y -47.0% vs +36.2% ยท 52W Pos 3% vs 38%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0
INDP NASDAQ
Indaptus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$2.82
-9.9% 1D
Market Cap $480.8M
1M Return -5.69%
1Y Return +36.23%
Forward P/E N/M
Unified AI Score
49.5 / 100 HOLD
Tech 30.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OKYO -47.03% INDP +36.23% Spread: +83.26 pp (INDP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OKYO TTM Op. Margin: 0.0% INDP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs INDP. Trailing 12-month operating profitability (OKYO 0.0% vs INDP 0.0%) and valuation multiples (OKYO N/M vs INDP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OKYO (2) vs INDP (3)
Institutional Metric OKYO INDP Criterion Row Winner
Market Capitalization Scale $62.7M $480.8M Larger Scale INDP
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -263.8% -318.0% Higher ROE OKYO
52-Week Range Position Momentum 3% ($1โ€“$3) 38% ($1โ€“$6) Stronger Trend INDP
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 76% Vol 1.18ฮฒ ยท 99% Vol Lower Realized Risk OKYO
Unified Institutional Score Composite Signal 42.8 / 100 (HOLD) 49.5 / 100 (HOLD) Higher Composite INDP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OKYO vs INDP Buy Guide
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
INDP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live INDP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OKYO nor INDP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.